These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
9. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Mohandas B, Mehta JL. Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545 [Abstract] [Full Text] [Related]
10. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005 Sep; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related]
11. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Schonberg MA, Davis RB, Wee CC. Womens Health Issues; 2005 Sep; 15(4):187-95. PubMed ID: 16051110 [Abstract] [Full Text] [Related]
14. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H. Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798 [Abstract] [Full Text] [Related]
15. Postmenopausal hormone therapy and the risk of cardiovascular disease. Bittner V. Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274 [Abstract] [Full Text] [Related]
17. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM, Naftolin F, Brinton EA, Judelson DR. Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [Abstract] [Full Text] [Related]